Cargando…

Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung

Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) has been known to increase diagnostic accuracy in differentiating benign and malignant lung lesions and to improve identification of lymph node and extrathoracic metastasis in pulmonary neoplasms. In this review, the author...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Semin, Lee, Kyung Soo
Formato:	Texto
Lenguaje:	English
Publicado:	e-Med 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151326/ https://www.ncbi.nlm.nih.gov/pubmed/18055292 http://dx.doi.org/10.1102/1470-7330.2007.0028

Ejemplares similares

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication
por: Balogova, Sona, et al.
Publicado: (2022)

Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT
por: Kaemmerer, Daniel, et al.
Publicado: (2011)

The Advantage of PET and CT Integration in Examination of Lung Tumors
por: Lu, Guangming, et al.
Publicado: (2007)

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
por: Liu, Yiyan
Publicado: (2008)

(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
por: Mirzaei, Siroos, et al.
Publicado: (2019)

Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
por: Calabrò, Diletta, et al.
Publicado: (2020)

Incidental PET/CT Findings of Suspected COVID-19 in a Region of High Prevalence
por: Franceschi, Ana M, et al.
Publicado: (2020)

Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
por: Schreiter, Nils Friedemann, et al.
Publicado: (2014)

(18)F-FDG PET/CT Imaging of Primary Hepatic Neuroendocrine Tumor
por: Mitamura, Katsuya, et al.
Publicado: (2015)

Testicular Metastasis of Jejunal Neuroendocrine Tumor on (68)Ga-DOTATATE PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023)

PET/CT imaging in lung cancer: indications and findings
por: Hochhegger, Bruno, et al.
Publicado: (2015)

Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung
por: Stefani, Alessandro, et al.
Publicado: (2013)

Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
por: Rufini, Vittoria, et al.
Publicado: (2022)

Splenosis Mimicking Relapse of a Neuroendocrine Tumor at Gallium-68-DOTATOC PET/CT
por: Treglia, Giorgio, et al.
Publicado: (2013)

Ileal Neuroendocrin Tumor Metastasis to Breast Diagnosed with Ga-68 DOTATATE PET/CT
por: Sağlampınar Karyağar, Sevda, et al.
Publicado: (2019)

Askin Tumor: CT and FDG-PET/CT Imaging Findings and Follow-Up
por: Xia, Tingting, et al.
Publicado: (2014)

FDG-PET/CT finding of benign metastasizing leiomyoma of the lung
por: Nakajo, Masatoyo, et al.
Publicado: (2012)

FDG-PET/CT findings of a metastatic pituitary tumor
por: Ilkhchoui, Yashar, et al.
Publicado: (2010)

Spectrum of [(18)F]FDG-PET/CT Findings in Benign Lymph Node Pathology
por: Zeman, Merissa N., et al.
Publicado: (2021)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
por: Resch, Katrin, et al.
Publicado: (2022)

Correction to: Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
por: Rufini, Vittoria, et al.
Publicado: (2022)

(18)F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
por: Qin, Chunxia, et al.
Publicado: (2020)

Impact of unknown incidental findings in PET/CT examinations of patients with proven or suspected vascular graft or endograft infections
por: Husmann, Lars, et al.
Publicado: (2021)

Application of (68)Ga-DOTA-TATE PET/CT in metastatic neuroendocrine tumor of gastrointestinal origin
por: Papadakis, Georgios Z., et al.
Publicado: (2017)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
por: Fine, Gabriel C., et al.
Publicado: (2022)

Widespread micronodular hepatic metastases of neuroendocrine tumor detected by [(68)Ga]DOTATATE PET/CT
por: D'Souza, Julia C., et al.
Publicado: (2022)

Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT
por: Oh, Sowon, et al.
Publicado: (2011)

Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors
por: Hou, Guozhu, et al.
Publicado: (2021)

MRI, CT and FDG-PET/CT findings of Wolffian tumor: four-case series
por: Ito, Hisataka, et al.
Publicado: (2021)

Lung Cancer Screening with Low-Dose Helical CT in Korea: Experiences at the Samsung Medical Center
por: Chong, Semin, et al.
Publicado: (2005)

Role of (18)F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis
por: Park, Soo Bin, et al.
Publicado: (2018)

Dedifferentiated liposarcoma lung metastases with different FDG-PET/CT findings
por: Imamura, Yoshito, et al.
Publicado: (2023)

Assessment of spatial tumor heterogeneity using CT growth patterns estimated by tumor tracking on 3D CT volumetry of multiple pulmonary metastatic nodules
por: Yoo, Jeongin, et al.
Publicado: (2019)

Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of (68)Ga DOTA-TATE PET/CT, (111)In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
por: Froelich, Matthias Frank, et al.
Publicado: (2021)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
por: Kunz, Wolfgang G., et al.
Publicado: (2018)

Diagnosing microscopic pancreatic neuroendocrine tumor using 68-Ga-DOTATATE PET/CT: case series
por: Barrio, Martin, et al.
Publicado: (2018)

Ga-DOTA PET/CT: the first-line functional imaging modality in the management of patients with neuroendocrine tumors
por: Mesquita, Cláudio Tinoco, et al.
Publicado: (2022)

Imaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases
por: Burns, Natalie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mdu7cgbkkvr2e4gdu0747mqejb